Mogrify Limited (Mogrify®) today announced the introduction of EpiMOGRIFY. The platform models the epigenetic state of the cell to predict the switches important for cell identity, cell maintenance, directed differentiation and cell conversion.

Specialty chemicals manufacturer FAR Chemical is using Matrix Gemini LIMS to improve the efficiency of its operations By significantly reducing the time taken to test and approve samples in the laboratory, the hold-times of products in the reactors have been cut and the efficiency of the entire operation improved.

Metrohm is proud to announce the launch of the Misa. Misa is Metrohm’s newest Raman spectrometer that detects trace contaminants in even the most complex food samples.

Impel NeuroPharma announced that it has presented patient-reported outcomes data from the Company’s pivotal Phase 3, open-label study “STOP 301” of INP104 (dihydroergotamine mesylate) or DHE using the company’s proprietary POD technology, for the treatment of acute migraine in an oral presentation at the Migraine Trust Virtual Symposium (MTIS) to be held from October 3-9, 2020.

CellGenix GmbH, announces the completion of the second phase of their facility expansion. By implementing an automated filling and freeze-drying line and increasing bulkware production footprint, finished product capacity for cytokines is substantially increased.

WeWALK has joined Microsoft’s AI for Accessibility programme to accelerate WeWALK’s capability by developing and validating a human behaviour model and creating a Voice Assistant for visually impaired users, providing the right mobility information when needed and allowing for even greater control of the WeWALK mobility experience.

Mologic Ltd, today announced the launch of its first crop pathogen diagnostic test, BotrytisAlert. Mologic has developed and trialled BotrytisAlert with Berry Garden Growers, NIAB EMR and the Warwickshire College. Using spore sampling devices, the consortium tested crop bioaerosols for Botrytis to drive early warning of disease potential on exposed crops.

PerkinElmer, Inc., today announced that the first Turnkey Lighthouse lab in Newport, South Wales, is now processing COVID-19 testing samples in support of the UK Government’s Test and Trace strategy. The Newport facility began processing its first samples on Monday, October 5th and is expected to deliver up to 20,000 samples daily by the end of October with PerkinElmer’s SARS-CoV-2 RT-PCR kits and workflow solutions.

Samsung’s new R&D facility in San Francisco will offer rapid, high-quality development services, including cell line development, to its global customers.

Bio-Rad Laboratories, Inc. today announced the global launch of its CFX Opus 96 and CFX Opus 384 Real-time PCR Systems along with BR.io, a cloud-based instrument connectivity, data management, and analysis platform.